Calidi Biotherapeutics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Calidi Biotherapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $45.0 thousand for the year ending 2022.

  • This data is from Calidi Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 15, 2024.
  • XBRL data for this metric is available from 2022 to 2022 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: